Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care

This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the interpretation of fundus photographs obtained by trained nursing assistant using a portable fundus camera in a primary care setting, compared with images obtained by the same method, but interpreted by ophthalmologists.

NCT Number	NCT07236879
Lead Sponsor	Hospital de Clinicas de Porto Alegre Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil, TelessaúdeRS / UFRGS
Conditions	Diabetic Retinopathy
Enrollment	922 participants
Start Date	2024-08-08
Primary Completion	2026-08 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2025-11-19